SCHEMBL7646258

SCHEMBL7646258

NC(CC[PH](=O)O)c1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.39
CYP2C9 P11712 3/20 0.39
MEN1 O00255 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
KMT2A Q03164 2/20 0.39
GABBR2 O75899 6/20 0.38
GABBR1 Q9UBS5 6/20 0.38
LMNA P02545 3/20 0.38
CYP1A2 P05177 2/20 0.38
THRB P10828 2/20 0.38
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
NFKB1 P19838 1/20 0.38
DRD3 P35462 1/20 0.38
BLM P54132 1/20 0.38
SCN4A P35499 2/20 0.37
MAPT P10636 1/20 0.37
PMP22 Q01453 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1882703 0.90 CYP2C9 (0.37) ADRB2CYP2C9MEN1CYP2D6CYP2C19
SCHEMBL1881772 0.79 GABBR2 (0.54) CYP2C9MEN1CYP2D6CYP2C19KMT2A
SCHEMBL390483 0.76 ADRB2 (0.43) ADRB2CYP2C9MEN1CYP2D6CYP2C19
SCHEMBL391358 0.75 ADRB2 (0.46) ADRB2CYP2C9MEN1CYP2D6CYP2C19
SCHEMBL16649881 0.75 ADRB2 (0.46) ADRB2CYP2C9MEN1CYP2D6CYP2C19
SCHEMBL390400 0.75 ADRB2 (0.46) ADRB2CYP2C9MEN1CYP2D6CYP2C19
SCHEMBL16649759 0.74 SLC6A4 (0.50) ADRB2CYP2C9MEN1CYP2D6CYP2C19
SCHEMBL1534396 0.74 SLC6A4 (0.50) ADRB2CYP2C9MEN1CYP2D6CYP2C19
SCHEMBL3834911 0.73 CYP2C9 (0.51) ADRB2CYP2C9MEN1CYP2D6CYP2C19
SCHEMBL3834914 0.73 CYP2C9 (0.51) ADRB2CYP2C9MEN1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100871-A1 NEW COMPOUNDS USEFUL IN REFLUX DISEASE ASTRAZENECA AB (SE) 2002-12-19 WO claimed
WO-2002100871-A1 NEW COMPOUNDS USEFUL IN REFLUX DISEASE ASTRAZENECA AB (SE) 2002-12-19 WO disclosed